Stated reasons for those seen again within 6 months included a change made to the thyroid hormone dose (11%), ongoing monitoring of other endocrine conditions (9%), pregnancy (6%), symptom assessment (5%), initiation of a new thyroid medication that required monitoring (3%), change in the thyroid medication type or brand (3%), monitoring of serum thyroid function tests (3%), medication compliance issues (2%), planned thyroid nodule fine needle biopsy (1%), planned repeat thyroid ultrasound (1%), or unclear (10%). Here, TG is linked to thyroid nodule.